DUBLIN--(BUSINESS WIRE)--The "Asia Pacific Cold Plasma Market Analysis, Companies Profiles, Size, Share, Growth, Trends and Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
Asia Pacific cold plasma market is expected to reach USD 534.4 million by 2025 from USD 154.7 million in 2017, at the highest CAGR of 16.9% in the forecast period 2018 to 2025. The new market report contains data for historic years 2016, the base year of calculation is 2017 and the forecast period is 2018 to 2025.
On the basis of regime type Asia Pacific cold plasma market is segmented into low pressure and atmospheric pressure. In 2018, atmospheric pressure is estimated to rule with 62.1% shares and will cross USD 335.3 million by 2025, rising at the highest CAGR of 17.0%.
On the basis of technology Asia Pacific cold plasma market is segmented into remote treatment, direct treatment and electrode contact. In 2018, direct treatment segment is estimated to rule with 63.32% shares and will cross USD 341.7 million by 2025, rising at the CAGR of 17.0%. However, remote treatment segment is expected to grow at the highest CAGR of 17.5% in the forecast period,
- Nordson Corporation
- Adtec Plasma Technology Co., Ltd.
- Bovie Medical
- CPI Plasma
- Enercon Industries Corporation
- Henniker Plasma
- Neoplas tools GmbH
- Plasmatreat GmbH
- Tantec A/S
- Terraplasma Medical GmbH
- TheraDep Technologies, Inc.
- Tomi Environmental Solutions, Inc.
- Vetaphone A/S
- Wacker Chemie AG
Key Topics Covered:
2. Market Segmentation
3. Market Overview
4. Executive Summary
5. Premium Insights
6. Asia-Pacific Cold Plasma Market, By Regime Type
7. Asia-Pacific Cold Plasma Market, By Technology
8. Asia-Pacific Cold Plasma Market, By Industry
9. Asia-Pacific Cold Plasma Market, By Geography
10. Asia-Pacific Cold Plasma Market, Company Landscape
11. Company Profiles
12. Related Reports
For more information about this report visit https://www.researchandmarkets.com/research/ttl5gf/asia_pacific_cold?w=4